Abstract
Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.
| Original language | English |
|---|---|
| Pages (from-to) | 97-99 |
| Number of pages | 3 |
| Journal | Bone Marrow Transplantation |
| Volume | 21 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1998 |
Keywords
- Allogeneic transplant
- Mantle cell lymphoma
Fingerprint
Dive into the research topics of 'Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver